Estrogen replacement therapy (ERT) is witnessing a level of high popularity among women to treat menopausal symptoms and thus has led to the growth of global ERT market according to a new report by Transparency Market Research (TMR), titled “Estrogen Replacement Therapy (ERT) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024.” The report speaks about the rising demand for the therapy and the reasons behind it. The report mentions the growing awareness about menopausal symptoms, the treatment options for the same, and the rising numbers of post-menopausal women across the globe needing the ERT as the main factors behind the development of the ERT market.
The rising demand for ERT resulted in the introduction of various safety treatment measures such as vaginal estrogen drugs and transdermal estrogen patches for the patients. To tackle the safety concerns arising because of high-dose treatment, low-dose ERT treatment are used. The report suggests that during the forecast period, the global market for ERT is expected to grow at a great pace as the conventional non-hormonal treatment is proving to be less effective than ERT.
One of the factors that might impede the growth of the ERT market is the high treatment cost of the therapy. The average monthly cost for the ERT differs from US$40 to US$150. Thus, affording such costly treatment can be a big concern for the population in emerging and underdeveloped nations. Another factor that may obstruct the growth of the ERT market is the potential risk of developing cervical cancer and coronary disease with prolonged use of the treatment.
The global ERT market is mainly categorized on the basis criteria such as routes of administration, end user, dosage form, and geography. Based on the dosage form, the ERT market can be divided into tablet, patches, suppositories, gels/creams, injections and implants. In 2015, the tablet dosage form dominated the ERT market. But it is expected that the market for other dosage forms like patches, gels/creams, and injections will see a rise because of the demand for effective long-term treatment and increasing safety concerns.
On the basis of the routes of administration, the market is categorized into segments such as oral, subcutaneous pellets, tropical, and injections. Of these, the oral route of administration is presently the most popular category. But in the recent past, other drug delivery systems like topical and subcutaneous products have observed rising requirement and acceptance in the ERT market.
From a geographical standpoint, the market in North America, especially the U.S., dominated the global ERT market in the recent past, followed by Western Europe and Japan. High cost of the treatment has been a key factor for its less-promising demand in emerging economies. But with rising population and increased awareness about healthcare, the market is witnessing rapid growth in the Asia-Pacific region as well.
Some of the leading players in the global ERT market are Bayer AG, Hisamitsu Pharmaceutical Co., AbbVie Inc., Orion Pharma AB, and Meda Pharmaceuticals.
Download a PDF Brochure of Report on ERT Market – http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13460